U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by dry on Thursday January 24 2019, @06:42AM
Canada has 14 government insurance systems. We also have some of the most expensive drugs in the world, 2nd highest I believe, partially due to the fractured healthcare.